Ignota Labs modifies the molecular structures of shelved drug candidates that failed clinical trials due to organ toxicity to advance them into stage-two trials

552c7ae14Topic

Drug Policy, Pricing & Approval

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

1 debate·7,769 claims·635 news stories

0